Bladder Cancer Immunotherapy: BCG and Beyond

Mycobacterium bovis bacillus Calmette-Guérin (BCG) has become the predominant conservative treatment for nonmuscle invasive bladder cancer. Its mechanism of action continues to be defined but has been shown to involve a T helper type 1 (Th1) immunomodulatory response. While BCG treatment is the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Askeland, Eric J., Newton, Mark R., O'Donnell, Michael A., Luo, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388311/
https://www.ncbi.nlm.nih.gov/pubmed/22778725
http://dx.doi.org/10.1155/2012/181987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388311/
https://www.ncbi.nlm.nih.gov/pubmed/22778725
http://dx.doi.org/10.1155/2012/181987

Ejemplares similares